Lung Fibrosis Is Improved by Extracellular Vesicles from IFNγ-Primed Mesenchymal Stromal Cells in Murine Systemic Sclerosis

Background: Systemic sclerosis (SSc) is a severe autoimmune disease for which mesenchymal stromal cells (MSCs)-based therapy was reported to reduce SSc-related symptoms in pre-clinical studies. Recently, extracellular vesicles released by MSCs (MSC-EVs) were shown to mediate most of their therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozier, Pauline, Maumus, Marie, Maria, Alexandre Thibault Jacques, Toupet, Karine, Jorgensen, Christian, Guilpain, Philippe, Noël, Danièle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535048/
https://www.ncbi.nlm.nih.gov/pubmed/34685707
http://dx.doi.org/10.3390/cells10102727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535048/
https://www.ncbi.nlm.nih.gov/pubmed/34685707
http://dx.doi.org/10.3390/cells10102727

Ejemplares similares